MediClin AG is a Germany-based company. The Company is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. It focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.

Employees

7,048

Sector

Healthcare Facilities & Services

Calendar

11-04 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-09-04	€5.500	0.00%	19
26-09-03	€5.500	+1.85%	1,150
26-09-02	€5.400	0.00%	5
26-09-01	€5.400	-1.82%	2,969
26-08-31	€5.500	0.00%	3,114

Delayed Quote Xetra

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.500EUR

Average target price

7.300EUR

Spread / Average Target

+32.73%

Consensus

Net sales - Rate of surprise

Company calendar

Market Closed - Xetra 11:35:22 2026-09-04 EDT			5-day change	1st Jan Change
5.500 ^EUR	0.00%		0.00%	+48.65%

07-31	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-04	MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	261M 304M 246M 225M 420M 28.66B 421M 2.9B 1.13B 14.71B 1.14B 1.12B 47.38B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	261M 304M 246M 225M 420M 28.66B 421M 2.9B 1.13B 14.71B 1.14B 1.12B 47.38B	EV / Sales 2026 *	0.33x	EV / Sales 2027 *	0.33x
Free-Float	12.27%	Yield 2026 *	0.73%	Yield 2027 *	0.73%

Markets		Quality
Xetra	MED	Delayed
Tradegate	MED	Real-time
CBOE		Real-time
Boerse Muenchen	MED	Real-time
Deutsche Boerse AG	MED	Delayed
Börse Stuttgart	MED	Delayed
CBOE	0NDG	Real-time

07-31	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-04	MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-04	MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026	CI
04-14	MEDICLIN Aktiengesellschaft announces Annual dividend, payable on June 02, 2026	CI
03-27	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Mediclin Aktiengesellschaft Provides Earnings Guidance for 2026	CI
11-04	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-08-01	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-07-31	MEDICLIN Aktiengesellschaft Provides Consolidated Earnings Guidance for the Full Year 2025	CI
25-05-02	MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-23	MEDICLIN Aktiengesellschaft announces Annual dividend, payable on June 10, 2025	CI
25-03-28	MEDICLIN Aktiengesellschaft Provides Group Earnings Guidance for 2025	CI
25-03-28	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2024	CI

MEDICLIN AG Stock

Stocks

MED

DE0006595101

Healthcare Facilities & Services

Valuation : MEDICLIN AG

Chart: MEDICLIN AG

Latest news : MEDICLIN AG

Press Releases : MEDICLIN AG

News in other languages : MEDICLIN AG

Quotes and Performance

Price Extremes

Managers and Directors : MEDICLIN AG

Hospitals, Clinics & Primary Care Services

Financials

Company Profile

Quotes

Analysts' Consensus

Net sales - Rate of surprise

07-30	MEDICLIN reports a solid first half of 2026	EQ
07-09	RPT: MEDICLIN AG: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution	EQ
05-29	MEDICLIN AG: Annual General Meeting approves all proposed resolutions	EQ
05-04	MEDICLIN increases group operating result in the first quarter	EQ
05-04	MEDICLIN : Interim report of MEDICLIN Aktiengesellschaft for the period from 1 January 2026 to 31 March 2026 PDF-File (338 KB) (Mediclin Q1 2026 E s)	PU

08-31	MEDICLIN : Doris Kölbl wird neue Kaufmännische Direktorin im MEDICLIN Reha-Zentrum Gernsbach
08-14	MEDICLIN CAMPUS Wertheim: Norbert Jäger ist neuer Klinikmanager
08-14	MEDICLIN Bliestal Kliniken: Nikolay Kolev ist Chefarzt der Kardiologie
07-30	MEDICLIN beendet solides erstes Halbjahr 2026
07-27	MEDICLIN : Sven Lazaar-Schepers übernimmt kommissarisch die Leitung der Orthopädie im MEDICLIN Klinikum Soltau

1 month	+27.31%
3 months	+30.95%
6 months	+45.50%
Current year	+48.65%

1 week	5.35	5.6
1 month	4.3	5.6
Current year	3.22	5.6
1 year	2.9	5.6
3 years	2.28	5.6
5 years	2.28	5.6
10 years	2.28	6.88

Manager	Title	Age	Since
Tino Marco Fritz CEO	Chief Executive Officer	50	-
Nicola Bertrand CTO	Chief Tech/Sci/R&D Officer	-	2024-06-30
Martin Buse CMP	Compliance Officer	-	-

Director	Title	Age	Since
Hans Hilpert BRD	Director/Board Member	60	2002-12-31
Michael Bock BRD	Director/Board Member	63	2005-05-24
Marco Walker BRD	Director/Board Member	50	2020-09-23

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDICLIN AG	0.00%	0.00%	+84.56%	+88.36%	304M
IHH HEALTHCARE	-0.50%	-3.64%	+15.05%	+34.29%	17.37B
APOLLO HOSPITALS ENTERPRISE LIMITED	-0.48%	-2.13%	+10.83%	+73.54%	13.17B
ENCOMPASS HEALTH CORPORATION	-0.65%	+0.78%	-3.02%	+73.02%	12.01B
AIER EYE HOSPITAL GROUP CO., LTD.	+1.45%	+1.70%	-35.06%	-55.58%	11.58B
MANIPAL HEALTH ENTERPRISES LIMITED	-0.11%	-6.02%	-	-	10.1B
THE ENSIGN GROUP, INC.	-0.76%	-1.27%	-1.84%	+78.71%	9.87B
BANGKOK DUSIT MEDICAL SERVICES	-0.97%	+4.62%	-2.86%	-24.44%	9.86B
RAMSAY HEALTH CARE LIMITED	+0.95%	+1.47%	+55.35%	+4.04%	8.68B
PURE HEALTH HOLDING	-0.76%	+1.16%	-9.66%	-	7.93B
Average	-0.18%	-0.34%	+12.60%	+33.99%	10.09B
Weighted average by Cap.	-0.22%	-0.67%	+3.80%	+28.92%

	2026 *	2027 *
Net sales	787M 915M 741M 677M 1.27B 86.4B 1.27B 8.76B 3.4B 44.33B 3.44B 3.36B 143B	803M 933M 756M 690M 1.29B 88.13B 1.29B 8.93B 3.47B 45.22B 3.51B 3.43B 146B
Net income	36.66M 42.61M 34.49M 31.51M 58.95M 4.02B 59.11M 408M 158M 2.06B 160M 156M 6.65B	38.2M 44.39M 35.94M 32.83M 61.41M 4.19B 61.58M 425M 165M 2.15B 167M 163M 6.93B
Net Debt	-	-